Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases

• Główni autorzy: Vishakha Singh (Autor), Amit Khurana (Autor), Prince Allawadhi (Autor), Anil Kumar Banothu (Autor), Kala Kumar Bharani (Autor), Ralf Weiskirchen (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Programmed cell death protein 1 (PD-1)/PD-ligand (L)1, the immune checkpoint inhibitors have emerged as a promising strategy for the treatment of various diseases including chronic liver diseases (CLDs) such as hepatitis, liver injury and hepatocellular carcinoma (HCC). The role of PD-1/PD-L1 has be...